OUR MISSION
· Remove the fear and pain associated with opioid withdrawal.
· Provide a compassionate and effective detox option.
· Increase treatment participation.
About Us
On May 2nd 2018, the Morph Device was granted a 510(k) clearance by the U.S. Food & Drug Administration. The device was cleared for Therapeutic Neuromodulation Systems to use as an aid in the treatment of opioid withdrawal.
Therapeutic Neuromodulation Systems, LLC is a U.S.-based sales and marketing organization. We are committed to our mission of using the Morph Device to increase treatment participation and remove the fear and pain associated with opioid withdrawal. Our experienced team of leaders are focused on creating a paradigm shift from traditional detox to the more humane method of the Morph Device.
We are passionate about establishing a vast distribution network of providers to make the Morph Device easily accessible to detox patients.
Leadership Team
The Therapeutic Neuromodulation Systems leadership team is comprised of successful professionals and entrepreneurs in the medical device field.
Arnold Rougee, President & Founder
Arnold Rougee has 27+ years of experience the private equity/mergers & acquisitions field. Mr. Rougee has initiated acquisitions in a variety of business sectors including the recycling industry, 3D graphic technology, film and production, construction services, industrial services, minerals and mining and a national car wash business. He has also played a major role in taking many of these ventures public. Mr. Rougee specializes in incubating emerging technologies, raising investment capital and bringing these technologies to market. He is experienced with new business development, contract negotiations, contract management and construction project management.
Rok Zaloznik, President of MAI/TNS Medical Technology
Rok Zaloznik is a distinguished expert in AI technologies, programming, and regulation, with extensive hands-on experience across various AI projects in the financial, medical, and regulatory sectors. As the President and Cofounder of the Swiss AI Association, he plays a pivotal role in bringing together stakeholders from various fields of AI, consulting new startups, building AI communities, and guiding companies on how to integrate AI into their daily business activities. Throughout his career, Rok has served as CTO and CIO for numerous Financial Institutions and AI startups, leveraging his deep understanding of artificial intelligence to drive innovation and growth. His expertise is further exemplified by his role as the architect behind a pioneering AI certification initiative, demonstrating his commitment to advancing the field of AI. With over 20 years of experience as a dynamic Senior IT Manager, Rok has led cross-functional teams in the banking, telecom, and IT industries. He has successfully delivered transformative AI, ML, and cloud-based solutions, showcasing his ability to drive digital transformation, align technology with business objectives, and manage high-impact projects with a focus on innovation and compliance. Rok’s multifaceted experience and leadership in the AI industry make him a valuable asset in the rapidly evolving landscape of artificial intelligence and its applications across various sectors.
DR. Hong Phan, CEO of MAI Medical Technology
Dr Hong Phan studied medicine at the Charité in Berlin and did research at the University of Zurich in collaboration with Johns Hopkins University. In addition to his work as a specialist in general medicine and family practice, he is dedicated to the research and development of innovative technologies in the fields of artificial intelligence, medical technology, longevity, blockchain, data management and nutritional supplements. To this end, he has founded several companies, including Mai Medical AG, Octane Nutrition, MaiDoc.ai and Mai Medtech Solutions. As a member of the Swiss AI Association, Purpur Ventures and Dwinity, he is developing a revolutionary and holistic medical AI with the aim of improving the quality of medicine for patients and doctors by focusing on prevention and improving collaboration in research and teaching. With his experience in neuroscience, holistic medicine, blockchain, AI and medical technology, he is developing the latest medical devices with AI and a holistic health system with Mai Medical and Mai TNS Medtech to make these life-saving and health-promoting technologies available to everyone in the world.
William J. Fisher, Esq., General Counsel
William Fisher serves as the President and CEO of DSRA, CX Solutions, Bass Reports and Central Surveys. Mr. Fisher is keenly engaged in the strategic consulting, new business development and client relations for these companies. Under Mr. Fisher’s leadership, DSRA has established long-term research and consulting relationships with a host of Fortune 500 firms. Mr. Fisher is an experienced corporate attorney in the mergers & acquisitions field, with transactions totally nearly $200 million dollars. Mr. Fisher received his Juris Doctorate from Texas A&M University School of Law and is licensed to practice in several jurisdictions. He is a member of the American Bar Association, The American Trial Lawyers Association and one of a handful of attorneys licensed to practice before the United States Supreme Court. Mr. Fisher has also authored multiple business articles in scholarly publications like Texas Lawyer.
Matt Lawhon, JD, FDA Compliance Attorney
Matt Lawhon serves as external legal counsel. Mr. Lawhon’s unique background in both law enforcement and legal counsel delivers the necessary experience to help Therapeutic Neuromodulation Systems, LLC (TNS) navigate the heavily regulated environment. For over a decade, Mr. Lawhon investigated healthcare fraud and abuse – first as a senior investigator for the Medicare Benefits Integrity Contractor in Texas (now UPIC) and then as a criminal investigator for the Texas Attorney General’s Medicaid Fraud Control Unit (MFCU). As an accomplished healthcare investigator, Mr. Lawhon developed an in-depth knowledge of the major healthcare laws governing healthcare delivery practices such as Anti-Kickback, Stark, the False Claims Act and the Sunshine Act. As an attorney, Mr. Lawhon uses this valuable knowledge to provide the guidance and counsel necessary to allow TNS to grow as a leader in the addiction treatment industry while maintaining compliance under the law. Mr. Lawhon is the owner of the M B Lawhon Law Firm PLLC. Bar Admissions: State of Texas, Northern District of Texas.